REFERENCE
Wechowski JG, Tetlow AP, McEwan P, Woehl A, Currie CJ.Cost-utility analysis in a UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients - a discrete event simulation model. Value in Health 9: A190 (plus oral presentation) abstr. G13, No. 6, Nov-Dec 2006
Garcia-Contreras F, Constantino-Casas P, Nevarez-Sida A, Del Angel-García G, García-Constantino M, Rojas-Martínez E.Economic evaluation of the pharmacological therapy of bleeding esophageal varices in Mexico. Value in Health 9: A244 (plus poster) abstr. PG111, No. 6, Nov-Dec 2006
Rights and permissions
About this article
Cite this article
Terlipressin stems cash flow in bleeding oesophageal varices. Pharmacoecon. Outcomes News 516, 5 (2006). https://doi.org/10.2165/00151234-200605160-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605160-00007